Skip to content

Atrial Fibrillation and Non-obstructive Coronary Lesions

Is Atrial Fibrillation is Associated With Non-significant Coronary Angiography Findings?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04537507
Acronym
AF-CAD
Enrollment
8000
Registered
2020-09-03
Start date
2010-01-31
Completion date
2022-01-31
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases, Coronary Artery Disease, Fibrillation, Atrial

Keywords

Fibrillation, Atrial, Coronary Artery Disease, Chronic Kidney Disease

Brief summary

Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with excessive risk of ischemic stroke and heart failure as well as reduced life expectancy. On the other hand, chronic coronary syndromes (CCS) remains the main cause of morbidity and mortality in an aging population. Both disease entities share common risk factors such as hypertension, diabetes and obesity The purpose of the study is to investigate the hypothesis indicating lack of significant coronary lesions in AF vs. sinus rhythm (SR) patients.

Detailed description

Atrial fibrillation (AF) and chronic coronary syndromes (CCS) share common risk factors and both disease entities frequently co-exist. Additionally, AF symptoms may mimic CCS. Objectives: To investigate the hypothesis indicating lack of significant coronary lesions in AF vs. sinus rhythm (SR) patients. The prevalence of CCS in patients with AF varies from 17% to 47% whereas AF in patients with CCS is much less common, ranging from 0.2% to 5.Patients with AF more often have concomitant CCS as compared with sinus rhythm controls. Additionally, AF is more frequently present in patients with either peripheral- or cerebrovascular artery disease than in non-atherosclerotic individuals We conducted a multi-center retrospective study including consecutive patients referred for elective coronary angiography.

Interventions

PROCEDURECoronary angiography

Sponsors

I.M. Sechenov First Moscow State Medical University
CollaboratorOTHER
Liverpool Heart and Chest Hospital NHS Foundation Trust
CollaboratorOTHER
Medical University of Gdansk
CollaboratorOTHER
Medical University of Bialystok
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Coronary angiography

Exclusion criteria

* We excluded patients with acute coronary syndromes (ACS), Tako-tsubo cardiomiopathy and history of ischemic heart disease, as well as those referred for coronary angiography before heart valve surgery. Prior cardiosurgical valve replacement was also the exclusion criterion.

Design outcomes

Primary

MeasureTime frameDescription
Coronary artery diseaseThrough study completion, an average of 8 yearsNumber of Participants with significant findings on coronary angiography

Countries

Poland, Russia, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026